Holen Sie sich die Stockscreener-App
2.35
1.29%
0.03
Enveric Biosciences Inc Aktie (ENVB) Neueste Nachrichten
Weekly Trades: Can SUUN sustain earnings growthMarket Growth Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent - Investing News Network
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Asianet Newsable
Biopharmaceutical company Enveric Biosciences announced today that Gilgamesh Pharmaceuticals has officially withdrawn its post-grant review request for a patent previously filed against Enveric Biosciences. - Bitget
Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested - Benzinga
Market Review: Does ARIS have declining or rising EPSMarket Movers & Reliable Breakout Forecasts - baoquankhu1.vn
Enveric Biosciences reports EB-003 receptor engagement assay data - Yahoo Finance
Is Enveric Biosciences Inc.’s ROE strong enoughGDP Growth & Growth Focused Stock Pick Reports - mfd.ru
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data - Investing News Network
Enveric’s lead drug candidate activates key pathways linked to depression relief - Investing.com Canada
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy - microdose.buzz
Enveric Biosciences (ENVB) stock: gains as EB-003 shows dual 5-HT₂A pathway activation - parameter.io
Enveric's EB-003 Assay Data Shows Dual 5-HTA Pathway Engagement; Stock Up - Nasdaq
Enveric Biosciences stock soars after revealing new data on lead drug candidate - Investing.com Australia
Enveric Stock Surges After Licensed Trademark Deal - timothysykes.com
Enveric Biosciences (ENVB) Reveals Promising Data on Lead Candidate EB-003 - GuruFocus
Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals - Benzinga
US Market Recap: What makes Enveric Biosciences Inc stock attractive todayJuly 2025 Institutional & Risk Managed Investment Entry Signals - baoquankhu1.vn
Will Enveric Biosciences Inc. stock outperform Dow Jones indexWeekly Loss Report & Safe Entry Point Identification - mfd.ru
What makes Enveric Biosciences Inc. stock attractive to growth funds2025 Technical Patterns & Expert Approved Trade Ideas - mfd.ru
Can Enveric Biosciences Inc. lead its sector in growthQuarterly Risk Review & Comprehensive Market Scan Insights - mfd.ru
Enveric Biosciences Nears Key Clinical Milestone with Novel Drug Candidate - AD HOC NEWS
Enveric Biosciences (ENVB) Files for Share Sale to Investors - GuruFocus
Why Enveric Biosciences Inc. stock remains on buy listsJuly 2025 Snapshot & Pattern Based Trade Signal System - mfd.ru
US Market Wrap: Is PEBK benefiting from innovation trendsMarket Volume Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Enveric Biosciences Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Growth Report: What is Enveric Biosciences Incs book value per shareWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Can Enveric Biosciences Inc sustain its profitabilityJobs Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Analyst Calls: Is Enveric Biosciences Inc a good ESG investmentQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
Fed Meeting: Can Magnite Inc grow without external fundingJuly 2025 Reactions & Verified Momentum Watchlists - baoquankhu1.vn
Enveric Biosciences registers $1.35 million in new shares under ATM agreement - Investing.com UK
Enveric Biosciences registers $1.35 million in new shares under ATM agreement By Investing.com - Investing.com India
Enveric Biosciences Registers Additional Shares for ATM Offering - TradingView
Enveric Biosciences (NASDAQ:ENVB) Trading Down 7.4% – Should You Sell? - Defense World
How does Enveric Biosciences Inc. score in quality rankingsAnalyst Upgrade & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enveric licenses RCANN trademark portfolio to TOTEC Pharma By Investing.com - Investing.com South Africa
Enveric Biosciences (ENVB) Licenses Trademark Portfolio to Totec Pharma - GuruFocus
Enveric Biosciences closes $1.5 million registered direct offering By Investing.com - Investing.com Australia
Is Enveric Biosciences Inc. being accumulated by smart money2025 Earnings Impact & Daily Technical Stock Forecast Reports - mfd.ru
Enveric licenses RCANN trademark portfolio to TOTEC Pharma - Investing.com
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option - Chartmill
Enveric Biosciences Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - TradingView
Enveric Biosciences Raises Capital Through Equity Offering - TipRanks
Enveric Biosciences closes $1.5 million registered direct offering - Investing.com
Enveric Biosciences Signs Securities Purchase Agreement With Institutional Investors - TradingView
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Caledonian Record
Enveric to sell 328,802 shares at $4.41 in registered direct offering - TipRanks
Enveric Biosciences raises $1.5 million in registered direct offering By Investing.com - Investing.com Canada
Enveric Biosciences (ENVB) Announces Stock and Warrant Offering - GuruFocus
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
1.18%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):